G E Gallick
Overview
Explore the profile of G E Gallick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gray M, Dallas N, Van Buren G, Xia L, Yang A, Somcio R, et al.
Oncogene
. 2020 May;
39(23):4619.
PMID: 32366906
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
2.
Jin J, Tien P, Cheng C, Song J, Huang C, Lin S, et al.
Oncogene
. 2014 May;
34(14):1811-21.
PMID: 24793790
Talins are adaptor proteins that regulate focal adhesion signaling by conjugating integrins to the cytoskeleton. Talins directly bind integrins and are essential for integrin activation. We previously showed that β1...
3.
Wu C, Liu S, Lee Y, Wang R, Sun S, Yin F, et al.
Oncogene
. 2013 May;
33(18):2385-94.
PMID: 23708659
Activation of the mitogen-activated protein kinase (MAPK) cascade in mammalian cell lines positively regulates the G2/M transition. The molecular mechanism underlying this biological phenomenon remains poorly understood. Ribosomal S6 kinase...
4.
Lee Y, Huang C, Murshed M, Chu K, Araujo J, Ye X, et al.
Oncogene
. 2010 Mar;
29(22):3196-207.
PMID: 20228840
Dasatinib, a dual Src family kinase and Abl inhibitor, is being tested clinically for the treatment of prostate cancer bone metastasis. Bidirectional interactions between osteoblasts and prostate cancer cells are...
5.
Kim M, Park S, Kopetz S, Gallick G
Cell Tissue Res
. 2008 Sep;
335(1):249-59.
PMID: 18815812
Src family kinases (SFKs) are signaling enzymes that have long been recognized to regulate critical cellular processes such as proliferation, survival, migration, and metastasis. Recently, considerable work has elucidated mechanisms...
6.
Gray M, Dallas N, Van Buren G, Xia L, Yang A, Somcio R, et al.
Oncogene
. 2008 Sep;
27(57):7192-200.
PMID: 18806828
During development inhibitor of DNA-bind-2 (Id2) regulates proliferation and differentiation. Id2 expression has been detected in cancer cells, yet its cellular function and validity as a therapeutic target remains largely...
7.
Lesslie D, Summy J, Parikh N, Fan F, Trevino J, Sawyer T, et al.
Br J Cancer
. 2006 May;
94(11):1710-7.
PMID: 16685275
Vascular endothelial growth factor (VEGF) is the predominant pro-angiogenic cytokine in human malignancy, and its expression correlates with disease recurrence and poor outcomes in patients with colorectal cancer. Recently, expression...
8.
Wey J, Gray M, Fan F, Belcheva A, McCarty M, Stoeltzing O, et al.
Br J Cancer
. 2005 Jun;
93(2):233-41.
PMID: 15956974
Neuropilin-1 (NRP-1) is a novel co-receptor for vascular endothelial growth factor (VEGF). Neuropilin-1 is expressed in pancreatic cancer, but not in nonmalignant pancreatic tissue. We hypothesised that NRP-1 expression by...
9.
Jung Y, Liu W, Reinmuth N, Ahmad S, Fan F, Gallick G, et al.
Angiogenesis
. 2002 Jan;
4(2):155-62.
PMID: 11806247
Small tumor vessels are composed of endothelial cells (ECs) and vascular smooth muscle cells (VSMCs). These cells have been shown to communicate with each other via cytokine signaling during neovascularization....
10.
Solorzano C, Jung Y, Bucana C, McConkey D, Gallick G, McMahon G, et al.
Cancer Res
. 2001 Oct;
61(19):7048-51.
PMID: 11585733
Alterations in endothelial cell (EC) signaling could serve as a marker of effective antiangiogenic therapy. We determined the effect of an antiangiogenic tyrosine kinase inhibitor, SU6668, on tumor EC signaling...